Immune reconstitution inflammatory syndrome (IRIS) is an aberrant inflammatory immune response that can be observed after initiation of antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infected patients with advanced immunodeficiency [1, 2] . One of the pathogens that is associated with IRIS is Mycobacterium avium complex (MAC) [3] [4] [5] [6] [7] . Although the incidence of MAC infection has decreased dramatically in the era of combination ART [8] , mortality from MAC infection remains high [9] , and MAC-IRIS continues to complicate the management of HIV-infected patients upon initiation of ART [5, [9] [10] [11] .
Appreciation of the pathogenesis of mycobacterial IRIS arises from data from patients with tuberculosis (TB) IRIS. The higher rates of IRIS in patients who initiated ART shortly after antimycobacterial treatment [12] [13] [14] and patients with positive sputum smears [15, 16] , cerebrospinal fluid cultures [17] , and higher levels of lipoarabinomannan in urine [18] suggest strong associations between antigen load and IRIS. Host immune responses, in particular, an exaggerated T-helper 1 (Th1) response, are thought to be critical in IRIS pathogenesis, given that patients with mycobacterial IRIS often have increased antigen-specific CD4 + T-cell responses after in vitro stimulation [19, 20] and elevated plasma levels of inflammatory cytokines such as tumor necrosis factor (TNF) and interferon gamma (IFN-γ) [21, 22] . This is further supported by data from a murine model where MAC-infected T-cell-deficient mice can develop IRIS after transfer of CD4 + T cells in a process that is dependent on the presence of IFN-γ-producing, antigen-specific CD4 + T cells [23] . Monocytes also play a role in TB-IRIS pathogenesis. Transcriptional studies comparing gene expression in monocytes isolated from patients with and without TB-IRIS have found differences in expression in >100 genes [24] . Plasma biomarkers of monocyte activation including soluble CD163 and soluble tissue factor, as well as ex vivo monocyte cytokine production, were also elevated in patients with TB-IRIS at baseline, prior to ART initiation, and further increased during IRIS [16] . The pathogenesis of MAC-IRIS has not been clearly delineated. Defective regulatory T cells and higher frequency of MACspecific CD4 + T cells in comparison with healthy controls have been described previously [25] . ) and cytotoxic potential that is accompanied by myeloid cell activation and production of inflammatory cytokines in peripheral blood and tissues in MAC-IRIS.
MATERIALS AND METHODS

Study Design and Patient Cohort
ART-naive patients with a CD4 + T-cell count <100 cells/µL enrolled in prospective studies at the National Institutes of Health (NIH) (NCT00286767, NCT02147405) were evaluated to identify those with MAC-IRIS. Similarly, HIV-uninfected patients with MAC infection enrolled in a natural history study of mycobacterial disease at the NIH (NCT00018044) were identified. All 3 studies were approved by the Institutional Review Board of the National Institute of Allergy and Infectious Diseases, and written informed consent was obtained from all participants prior to any study procedures.
Immunophenotyping and Stimulation Experiments
Cryopreserved peripheral blood mononuclear cells (PBMCs) were collected from a single time point in HIV-uninfected patients with MAC infection and at 3 time points in HIV-infected patients with MAC-IRIS; baseline (prior to ART initiation); during IRIS; and at week 48. Cells were then used for immunophenotyping and stimulation experiments, respectively (See Supplementary Methods).
Blocking Inhibitory Receptors Using Antibodies
PBMCs from HIV-infected patients with MAC-IRIS from baseline and IRIS time points were incubated with immunoglobulin G control or respective anti-inhibitory receptor antibodies, including anti-cytotoxic T-lymphocyte associated protein 4 (CTLA-4) antibody (Biolegend, clone L3D10, 5 μg/mL), antilymphocyte activation gene-3 (LAG-3) antibody (Abcam, clone 11E3, 20 μg/mL), anti-programmed cell death 1 (PD-1) antibody (Biolegend, clone EH12.2h7, 10 μg/mL), and anti-programmed cell death ligand-1 (PD-L1) antibody (Biolegend, clone 29E.2A3, 20 μg/mL), and stimulated with heat-inactivated, sonicated M. avium as described in the Supplementary Methods.
Confocal Microscopy of Lymph Node Aspirate and Bronchoalveolar Lavage
A subset of HIV-infected patients had lymph node fine-needle aspiration (n = 4) and bronchoalveolar lavage (BAL; n = 3) performed at the time of IRIS, and a subset of HIV-uninfected patients with MAC infection had BAL (n = 2) or lung fine-needle aspiration (n = 2) for diagnostic purposes. Tissue immunofluorescence was performed on these samples (Supplementary Methods).
Statistical Analysis
Comparisons between different time-points (baseline, IRIS, and week 48) in HIV-infected patients were analyzed using Wilcoxon signed-rank test. Comparisons between HIV-infected and HIVuninfected patients were analyzed using Mann-Whitney test. The inferential networks (host interactome) were generated from Spearman correlation matrices containing values of each biomarker measured in the plasma samples as well as frequencies of cytokine-producing monocytes or lymphocytes in PBMCs after in vitro MAC stimulation. In this analysis, each mediator is selected as a target, and the software program (JMP 13, SAS Institute) searches among the other mediators for those that are correlated, with the target calculating a correlation matrix using Spearman rank tests. Thus, the features related to the selected target are linked. The links shown in the networks represent highly statistically significant Spearman rank correlations (P < .05). We next employed bootstrapping (100×) of the correlation matrices. Only correlations remaining with P < .05 in at least 40 of 100 times were considered.
Statistical analyses were performed using R, JMP, and GraphPad Prism software.
RESULTS
Patient Characteristics
Thirteen HIV-infected patients with MAC-IRIS and 14 HIVuninfected patients with pulmonary MAC infection with available cryopreserved PBMCs were identified from 3 observational cohorts. All HIV-infected patients were ART naive at baseline. Nine HIV-infected patients had unmasking MAC-IRIS and 4 had paradoxical MAC-IRIS. Patients with paradoxical MAC-IRIS had been treated for MAC infection for 3-7 days prior to the initiation of ART. The median time between ART initiation and the onset of MAC-IRIS was 30 (interquartile range [IQR], 18-55) days. The majority of HIV-infected patients with MAC-IRIS were middle-aged black men, while the HIV-uninfected patients with MAC infections were mostly older white women (Table 1) Figure 2F ) also increased. In contrast, there was no significant increase in cytomegalovirus-specific CD4 + T-cell responses during the MAC-IRIS timepoint (Supplementary Figure 3) . To further characterize MAC-specific CD4 + T cells during IRIS, the expression of T-bet ( Figure 3A ) and Eomes ( Figure 3B ) was measured. T-bet is a T-box transcription factor that regulates Th1 cell differentiation and IFN-γ production [26, 27] . Eomes is also a T-box transcription factor that is involved with immunologic memory and cytotoxicity [28] . In the setting of chronic viral infection and immune exhaustion, T-bet expression is reduced and Eomes expression is upregulated [29, 30] . As shown in Figure 3C , Figure 3D ).
Exuberant MAC-Specific CD4 + T-Cell Responses During IRIS Were Not Attributed to an Abrupt Decrease in Inhibitory Signals or the Absence of Regulatory T Cells
Next, we sought to determine whether absence or reduction of inhibitory signals were associated with the massive increases This suggests that the exuberant CD4 + T-cell responses during IRIS are unlikely to be secondary to the absence of inhibitory receptor signaling. In fact, immune checkpoint inhibition is probably at work in IRIS, bridling CD4 + T-cell responses to some degree.
CD4 + T Cells and Monocyte/Macrophages Were Also Activated at Sites of IRIS Pathology
Many of the studies on mycobacterial IRIS have focused on peripheral blood but the inflammatory response is likely to be largely localized in tissues such as the lungs or the lymph nodes. Using confocal microscopy, we evaluated TNF expression in CD4 + and CD68 + cells in tissues at sites of IRIS pathology. We found that larger proportions of CD4 + cells and CD68 + monocytes/macrophages in tissue samples from HIV-infected patients with MAC-IRIS were expressing TNF when compared to HIV-uninfected patients with MAC infection ( Figure 5 ). These data mirrored the TNF production seen in PBMCs during in vitro stimulation assays.
Systemic Inflammatory Response Was Evident During IRIS, With Highly Elevated Plasma IFN-γ and C-Reactive Protein Levels
Plasma levels of IFN-γ, TNF, interleukin 10 (IL-10), C-reactive protein (CRP), D-dimer, soluble CD14, and IL-2 were all higher in HIV-infected patients at baseline compared with HIVuninfected patients ( , and interleukin 6 (IL-6) + (C) monocytes after 6 hours of stimulation with heat-inactivated MAC as measured by intracellular cytokine staining. The percentages of cytokine-producing monocytes between the 3 time points (baseline, IRIS, and week 48) within HIV-infected patients with MAC-IRIS were compared using Wilcoxon signed-rank test. Comparisons between HIV-infected patients and HIV-uninfected patients with MAC infection were made using Mann-Whitney test. Lines represent median and interquartile ranges, filled symbols denote patients with unmasking MAC-IRIS, and open symbols denote patients with paradoxical MAC-IRIS. *P < .05, **P < .01. 4B). HIV-uninfected patients, in contrast, had higher plasma myeloperoxidase (MPO) levels (Supplementary Figure 4C) . During IRIS, there was a significant increase in plasma IFN-γ (P = .048, Figure 6A ), CRP (P = .008, Figure 6D ), and MPO (P < .001, Supplementary Figure 4C) . Increase in plasma IL-6 levels did not reach statistical significance (P = .080, Figure 6F ), whereas IL-10 levels decreased (P = .008, Figure 6C ) compared with baseline.
Interactions Between T-Cell, Monocyte, and Plasma Cytokine and Inflammatory Markers
Using inferential network analysis with bootstrapping, we examined the relationships, between cytokine-producing monocytes and CD4 + T cells after in vitro MAC stimulation with plasma cytokine and inflammatory markers in HIV-infected patients with MAC-IRIS. At baseline (Supplementary Figure 4D) , plasma IL-6 levels correlated with IFN-γ + CD4 + T cells and plasma polyfunctional, expressing low levels of T-bet and high levels of Eomes. The T-bet low Eomes hi CD4 + T-cell phenotype is associated with inhibitory receptor expression and immune exhaustion. This is likely secondary to underlying advanced HIV infection [29, 30] . A proportion of MAC-specific CD4 + T cells also expressed markers of degranulation and showed cytotoxic potential. The robust MAC-specific CD4 + T-cell response during IRIS was also not secondary to a dramatic reduction in cell-associated inhibitory signals. The frequency of Tregs remained stable from baseline to IRIS and was comparable to patients without HIV infection. This is consistent with data from patients with TB-IRIS [35] . Weakly suppressive Tregs have previously been found in patients with MAC infection [25] . We were not able to test regulatory T-cell suppressive function. Other inhibitory receptors, such as PD-1 and CTLA-4, were present during IRIS, at levels higher than HIV-uninfected patients. Blocking of inhibitory receptors had minimal effects on the percentage of IFN-γ + CD4 + T cells at baseline. In contrast, CTLA-4 and LAG-3 blockade were associated with increases in the percentage of IFN-γ + CD4 + T cells during IRIS, suggesting that some degree of immune checkpoint control was active during IRIS. Plasma IL-10 levels dropped during IRIS when compared to baseline, a finding also noted by other studies [36, 37] . IL-10 has immunoregulatory and anti-inflammatory effects and can directly suppress T-cell activation and cytokine production [38, 39] . This supported the hypothesis that regulatory and inhibitory signals, though present, might have been inadequate to balance the exaggerated inflammatory responses [40] . In addition to in vitro data, we also found higher percentage of TNF-expressing CD4 + and CD68 + myeloid cells at the sites of IRIS pathology (lymph nodes and BAL). Furthermore, increased levels of IFN-γ and CRP were found in plasma, consistent with published data on patients with TB-IRIS [21, 22, 36] . HIV-infected patients with disseminated MAC infection. On the other hand, reduced MAC-specific CD4 + T cells might have contributed to the development of MAC infection in these patients given the critical role of IFN and TNF in the protection against MAC infection [41, 42] . These patients have been extensively investigated and no known immunodeficiencies were identified; the MAC infections did not disseminate and remained localized in the lung. It is also possible that myeloid responses (neutrophils, macrophages) may be playing a significant role as suggested by the high plasma MPO levels.
The use of HIV-uninfected patients with MAC infection as controls enabled the delineation of immune responses in IRIS from immune responses in active MAC infection without HIV infection. A limitation of this study was the lack of HIV/ MAC coinfected patients who did not develop IRIS as controls as MAC infection in the absence of IRIS is uncommon in our cohort, though incidence in the literature has been variable [9, 43] . We also considered the use of HIV-infected patients without MAC infection as controls, but with only 1 in 6 individuals in the United States being sensitized [44] , the absence of MAC-specific CD4 + T cells could be an effect of lack of exposure. Although this study had a relatively small sample size, it represents the largest cohort of MAC-IRIS patients with prospective study design, long-term follow-up, and PBMC collection. We studied patients with unmasking and paradoxical MAC-IRIS, although patients with paradoxical MAC-IRIS only received MAC therapy for 3-7 days prior to ART initiation and thus the antigen load at ART initiation was probably not substantially different. Furthermore, our data revealed no obvious differences in results between unmasking and paradoxical IRIS.
In conclusion, MAC-IRIS is characterized by the restoration of TNF + monocytes and exuberant cytokine-producing CD4 + T cells in vitro after stimulation with MAC, inflammatory cytokine production at the tissue sites of IRIS pathology, and systemic inflammation. We thus postulate that HIV infection with profound immunodeficiency leads to impairment in cytokine production by monocytes and macrophages, resulting in an inability to effectively control MAC infection, leading to accumulation of antigens [2] . Vigorous restoration of MAC-specific T-bet low cytokine-producing CD4 + T cells with cytotoxic potential in consort with monocyte/macrophage responses ensues after ART initiation, overwhelming available regulatory and inhibitory mechanisms and leading to IRIS.
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